Thursday, August 29, 2013

Israeli Company ‘Neuronix’ Offers Hope For Alzheimer’s Disease With Unique Treatment

By Adam Van Heerden, NoCamels

Alzheimer’s Disease currently affects between 30-35 million people around the world and according to the Alzheimer’s Disease Facts and Figures Report, this number will double by 2030.

AlzheimersIsraeli company Neuronix has developed what may be the most advanced non-invasive treatment for the disease, which is so far incurable.

According to Neuronix, its treatment, which involves magnetic stimulation to the brain, can restore a patient’s cognitive ability to a state comparable to that of two years before the treatment began.

“The greatest concern in the medical community”
According to Eyal Baror, CEO of Neuronix, “Alzheimer’s Disease (AD) is one of the greatest concerns in the medical community today. AD is the only disease this widespread for which there is no cure, vaccine, or any other way to stop it.”

According to the Facts and Figures Report, Alzheimer’s is the sixth cause of death globally and the only one in the top 10 that has not diminished, but rather increased by 66 percent between 2000 and 2008.

A real “game changer”

Baror is clear about the fact that neuroAD is not a cure. Nevertheless, he is confident that neuroAD is bringing about “a real change in the battle against AD.”

 Continue reading.

No comments:

Post a Comment